121 related articles for article (PubMed ID: 38565058)
1. Multitarget action of Benzothiazole-piperazine small hybrid molecule against Alzheimer's disease: In silico, In vitro, and In vivo investigation.
Mishra CB; Shalini S; Gusain S; Kumar P; Kumari S; Choi YS; Kumari J; Moku BK; Yadav AK; Prakash A; Jeon R; Tiwari M
Biomed Pharmacother; 2024 May; 174():116484. PubMed ID: 38565058
[TBL] [Abstract][Full Text] [Related]
2. Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease.
Bajad NG; Singh RB; T A G; Gutti G; Kumar A; Krishnamurthy S; Singh SK
Bioorg Chem; 2024 Feb; 143():107082. PubMed ID: 38199142
[TBL] [Abstract][Full Text] [Related]
3. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
4. In Silico and In Vitro Studies of Benzothiazole-Isothioureas Derivatives as a Multitarget Compound for Alzheimer's Disease.
Rosales Hernández MC; Fragoso Morales LG; Correa Basurto J; Olvera Valdez M; García Báez EV; Román Vázquez DG; Anaya García AP; Cruz A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361729
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Multitarget-Directed Ligands from Piperidine Alkaloid Piperine as a Cap Group for the Management of Alzheimer's Disease.
Bhanukiran K; Singh SK; Singh R; Kumar A; Hemalatha S
ACS Chem Neurosci; 2023 Aug; 14(15):2743-2760. PubMed ID: 37433759
[TBL] [Abstract][Full Text] [Related]
6. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease.
Singh YP; Tej GNVC; Pandey A; Priya K; Pandey P; Shankar G; Nayak PK; Rai G; Chittiboyina AG; Doerksen RJ; Vishwakarma S; Modi G
Eur J Med Chem; 2020 Jul; 198():112257. PubMed ID: 32375073
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
10. Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
Yelamanda Rao K; Jeelan Basha S; Monika K; Naidu Gajula N; Sivakumar I; Kumar S; Vadde R; Aramati BMR; Subramanyam R; Damu AG
J Biomol Struct Dyn; 2023 Dec; 41(20):11148-11165. PubMed ID: 37098803
[TBL] [Abstract][Full Text] [Related]
11. Unleashing new MTDL AChE and BuChE inhibitors as potential anti-AD therapeutic agents: In vitro, in vivo and in silico studies.
Zaafar D; Elghazawy NH; Hassan A; Mahmoud MY; Bakr AF; Arafa RK
Int J Biol Macromol; 2024 May; 268(Pt 1):131740. PubMed ID: 38653428
[TBL] [Abstract][Full Text] [Related]
12. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Xia J; Dong S; Yang L; Wang F; Xing S; Du J; Li Z
Bioorg Chem; 2024 Feb; 143():106980. PubMed ID: 38006789
[TBL] [Abstract][Full Text] [Related]
14. Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents.
Patel DV; Patel NR; Kanhed AM; Patel SP; Sinha A; Kansara DD; Mecwan AR; Patel SB; Upadhyay PN; Patel KB; Shah DB; Prajapati NK; Murumkar PR; Patel KV; Yadav MR
ACS Chem Neurosci; 2019 Aug; 10(8):3635-3661. PubMed ID: 31310717
[TBL] [Abstract][Full Text] [Related]
15. Attenuating Aβ1-42-induced toxicity by a novel acetylcholinesterase inhibitor.
Mishra N; Sasmal D; Singh KK
Neuroscience; 2013 Oct; 250():309-19. PubMed ID: 23872389
[TBL] [Abstract][Full Text] [Related]
16. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
17. A benzothiazole/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats.
Demir Özkay Ü; Can ÖD; Sağlık BN; Turan N
Pharmacol Rep; 2017 Dec; 69(6):1349-1356. PubMed ID: 29132093
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
20. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
Jiang N; Ding J; Liu J; Sun X; Zhang Z; Mo Z; Li X; Yin H; Tang W; Xie SS
Bioorg Chem; 2019 Aug; 89():103027. PubMed ID: 31176237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
